JP2015523074A5 - - Google Patents

Download PDF

Info

Publication number
JP2015523074A5
JP2015523074A5 JP2015520577A JP2015520577A JP2015523074A5 JP 2015523074 A5 JP2015523074 A5 JP 2015523074A5 JP 2015520577 A JP2015520577 A JP 2015520577A JP 2015520577 A JP2015520577 A JP 2015520577A JP 2015523074 A5 JP2015523074 A5 JP 2015523074A5
Authority
JP
Japan
Prior art keywords
protein
recombinant
item
optionally
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015520577A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015523074A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/048601 external-priority patent/WO2014005036A1/en
Publication of JP2015523074A publication Critical patent/JP2015523074A/ja
Publication of JP2015523074A5 publication Critical patent/JP2015523074A5/ja
Pending legal-status Critical Current

Links

JP2015520577A 2012-06-29 2013-06-28 組換えイズロン酸2スルファターゼの製造方法 Pending JP2015523074A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261666712P 2012-06-29 2012-06-29
US61/666,712 2012-06-29
PCT/US2013/048601 WO2014005036A1 (en) 2012-06-29 2013-06-28 Method of producing recombinant iduronate-2-sulfatase

Publications (2)

Publication Number Publication Date
JP2015523074A JP2015523074A (ja) 2015-08-13
JP2015523074A5 true JP2015523074A5 (enExample) 2016-08-12

Family

ID=49778402

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015520577A Pending JP2015523074A (ja) 2012-06-29 2013-06-28 組換えイズロン酸2スルファターゼの製造方法

Country Status (21)

Country Link
US (1) US20140004097A1 (enExample)
EP (1) EP2867367A4 (enExample)
JP (1) JP2015523074A (enExample)
KR (1) KR20150037908A (enExample)
CN (1) CN104583414A (enExample)
AU (1) AU2013282417A1 (enExample)
BR (1) BR112014032544A2 (enExample)
CA (1) CA2877492A1 (enExample)
CL (1) CL2014003569A1 (enExample)
CO (1) CO7240395A2 (enExample)
CR (1) CR20140587A (enExample)
DO (1) DOP2014000297A (enExample)
EA (1) EA201492185A1 (enExample)
HK (2) HK1209790A1 (enExample)
IL (1) IL236324A0 (enExample)
IN (1) IN2014DN11272A (enExample)
MX (1) MX2015000188A (enExample)
PE (1) PE20150603A1 (enExample)
PH (1) PH12014502870A1 (enExample)
SG (1) SG11201408755TA (enExample)
WO (1) WO2014005036A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160145589A1 (en) 2011-06-24 2016-05-26 Green Cross Corporation Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
KR101380740B1 (ko) 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
US9150841B2 (en) 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase
CA2880162C (en) 2012-07-31 2023-04-04 Bioasis Technologies, Inc. Dephosphorylated lysosomal storage disease proteins and methods of use thereof
CA2906003C (en) 2013-03-13 2021-07-06 Bioasis Technologies Inc. Fragments of p97 and uses thereof
EP3107562B1 (en) * 2014-02-19 2019-09-18 Bioasis Technologies Inc. P97-ids fusion proteins
KR102638596B1 (ko) 2015-02-05 2024-02-21 알.피.쉐러 테크놀러지즈 엘엘씨 활성화된 포르밀글리신-생성 효소 및 그것의 생산 및 사용 방법
CA3001483A1 (en) * 2015-10-07 2017-04-13 Joel HUIZENGA Resetting biological pathways for defending against and repairing deterioration from human aging
EP3373937B1 (en) 2015-11-09 2021-12-22 R.P. Scherer Technologies, LLC Anti-cd22 antibody-maytansine conjugates and methods of use thereof
CN109689191B (zh) * 2016-07-25 2021-11-19 瑞普利金公司 交替切向流快速收获
BR112020005271A2 (pt) 2017-10-02 2020-09-15 Denali Therapeutics Inc. proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2243827B2 (en) 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
ATE348173T1 (de) * 1999-04-26 2007-01-15 Genentech Inc Zellenzuchtverfahren für glycoproteine
US6890736B1 (en) * 2002-09-20 2005-05-10 Immunex Corporation Methods for producing proteins in cultured cells
US8227212B2 (en) * 2003-02-11 2012-07-24 Shire Human Genetic Therapies, Inc. Cell that expresses a sulfatase and a formylglycine generating enzyme
US20050019914A1 (en) * 2003-07-24 2005-01-27 Aventis Pharma Deutschland Gmbh Perfusion process for producing erythropoietin
WO2005113765A2 (en) 2004-05-06 2005-12-01 Biomarin Pharmaceutical Inc. Methods of activation of sulfatases and methods and compositions of using the same
PL2267024T3 (pl) * 2005-06-03 2012-10-31 Ares Trading Sa Wytwarzanie rekombinowanego białka wiążącego IL-18
CA2630782C (en) * 2005-12-08 2015-02-03 Amgen Inc. Improved host cells and culture methods
KR101744142B1 (ko) * 2008-01-18 2017-06-07 바이오마린 파머수티컬 인크. 활성이고 높은 정도로 인산화된 인간 리소좀 술파타아제 효소의 제조 및 그 용도
HUE044865T2 (hu) * 2009-10-09 2019-11-28 Armagen Inc Eljárások és készítmények a központi idegrendszerben iduronát-2-szulfatáz-aktivitás növelésére
WO2011109600A1 (en) * 2010-03-05 2011-09-09 Alnylam Pharmaceuticals, Inc. Compositions and methods for modifying the glycosylation pattern of a polypeptide
HRP20191924T1 (hr) 2010-06-25 2020-01-10 Shire Human Genetic Therapies, Inc. Postupci i sastavi za isporuku iduronat-2-sulfataze u cns
KR101158673B1 (ko) * 2011-06-24 2012-07-03 주식회사 지씨바이오 재조합 인간 이듀로네이트-2-설파타아제를 포함하는 조성물, 제제 및 이의 제조방법
US9150841B2 (en) * 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase

Similar Documents

Publication Publication Date Title
JP2015523074A5 (enExample)
JP5611822B2 (ja) ヘモフィルス・インフルエンザb型菌用の培養培地
CN112538453B (zh) 一种产核黄素的枯草芽孢杆菌及其构建方法与应用
CN103555658B (zh) 一种bhk-21细胞全悬浮培养的无血清培养基
CN103952419B (zh) 枯草芽孢杆菌腺苷琥珀酸合成酶突变基因purA及应用
Higuchi Cultivation of animal cells in chemically defined media, a review
CN112795531A (zh) 一种cho细胞无血清无蛋白培养基及其用途
CN108535489A (zh) 一种用于体外蛋白质合成的蛋白合成体系、试剂盒及其制备方法
WO2019024379A1 (zh) 新型融合蛋白的制备及其在提高蛋白质合成的应用
CN101195817A (zh) 一种杂交瘤细胞扩增培养基及其用途
Gray The respiratory metabolism of murine leprosy bacilli
CN101230373A (zh) 一种s-腺苷蛋氨酸的制备方法
CN111235169A (zh) 一种GTP环化水解酶I基因folE及应用
US20220267716A1 (en) Methods and compositions for culturing hemoglobin-dependent bacteria
US12173338B2 (en) Genetically engineered bacteria, its construction method and its application in producing NAD+ method
CN118530865B (zh) 一种异戊烯醇利用途径依赖的酿酒酵母工程菌及其构建方法与应用
ES2728970T3 (es) Microorganismos que tienen una productividad de L-aminoácidos potenciada y proceso de producción de Laminoácidos en el que se usan los mismos
CN112575021B (zh) 一种生产核黄素的方法
CN112342248B (zh) 一种基因敲除改变体外蛋白合成能力的方法及其应用
CN102653729B (zh) 一种用于中国仓鼠卵巢细胞的培养基
CN103409486A (zh) 一种通过流加次黄嘌呤提高腺苷发酵产量的方法
CN101870964B (zh) 一种提高sam合成酶表达量的方法
CN117535331A (zh) 一种生产辅酶q10基因工程菌的改造方法及其应用
CN107723302B (zh) 一种过表达产甘油假丝酵母CgGAD1提高渗透压耐受性的方法
CN114703243A (zh) 一种发酵生产腺苷的方法